Acquisition History / Zydus Lifesciences Ltd / Assertio Holdings Inc
Zydus Lifesciences Ltd Acquires Assertio Holdings Inc
Announced May 13, 2026 — $166.4M
What happened
Zydus Lifesciences agreed to buy US specialty pharma company Assertio Holdings for about $166.4 million in cash through Zydus Worldwide DMCC and merger vehicle Zara Merger Sub. The $23.50 per share offer topped rival Garda Therapeutics' revised $21.80 bid and was 75.8% above Assertio's unaffected price. The deal gives Zydus a ready-made US commercial platform.
- Acquirer
- Zydus Lifesciences Ltd
- Target
- Assertio Holdings Inc
- Announced
- May 13, 2026
- Price
- $166.4M
- Industry
- Specialty pharmaceuticals
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Zydus Lifesciences Ltd acquire Assertio Holdings Inc?
Zydus Lifesciences Ltd acquired Assertio Holdings Inc on May 13, 2026. This was Zydus Lifesciences Ltd's 3rd publicly tracked acquisition out of 3 we have on record.
How much did Zydus Lifesciences Ltd pay for Assertio Holdings Inc?
Zydus Lifesciences Ltd paid $166.4M for Assertio Holdings Inc.
What does Assertio Holdings Inc do?
Zydus Lifesciences agreed to buy US specialty pharma company Assertio Holdings for about $166.4 million in cash through Zydus Worldwide DMCC and merger vehicle Zara Merger Sub. The $23.50 per share offer topped rival Garda Therapeutics' revised $21.80 bid and was 75.8% above Assertio's unaffected price. The deal gives Zydus a ready-made US commercial platform.
What other Specialty pharmaceuticals companies has Zydus Lifesciences Ltd acquired?
Assertio Holdings Inc is Zydus Lifesciences Ltd's only publicly tracked acquisition in Specialty pharmaceuticals so far.
More Zydus Lifesciences Ltd acquisitions
Amplitude Surgical SA (85.6%)
$300.5M · 2025
Sterling Biotech Ltd - fermentation API business and Masa plant
$9.5M · 2024